Timed, sustained release multiparticulate dosage forms of propranolol

Details for Australian Patent Application No. 2002330211 (hide)

Owner Eurand Inc.

Inventors Venkatesh, Gopi M; Vishnupad, Krishna S; Percel, Phillip J

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002330211

PCT Number PCT/US02/31535

PCT Pub. Number WO2003/028708

Priority 09/971,167 04.10.01 US

Filing date 2 October 2002

Wipo publication date 14 April 2003

Acceptance publication date 1 February 2007

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/62 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 09/971,167 04.10.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002330211

27 July 2006 Assignment before Grant

  Eurand Pharmaceuticals Ltd The application has been assigned to Eurand Inc.

1 February 2007 Application Accepted

  Published as AU-B-2002330211

31 May 2007 Standard Patent Sealed

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002330212-COORDINATING HAPTICS WITH VISUAL IMAGES IN A HUMANCOMPUTER INTERFACE

2002330210-CONSOLIDATED IN-FLIGHT ENTERTAINMENT ELECTRONIC SYSTEM